Replies to post #430118 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

It’s called ramping. The point is those two facilities combined could ultimately ramp to 100,000 batches annually once Flaskworks becomes operative. That’s their likely capacity after ramping (if used for that). Not bad. Your 100,000 immediate FDA requirement is pure fiction, used to depress investor sentiment.

[Horseb4CarT]

On the contrary, as one might expect from the horseb4CarT, the FDA does consider the ability and readiness of adequate manufacturing for approvals.